Bone Mineral Density Status in Patients with Recent-onset Rheumatoid Arthritis

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2023 May 30

PMID 37250372

Authors

Arsh Haj Mohamad Ebrahim Ketabforoush

Mehdi Aleahmad

Mostafa Qorbani

Golbarg Mehrpoor

Sima Afrashteh

Shayan Mardi

Elahe Dolatshahi

Affiliations

Soon will be listed here.

Abstract

Background: Osteoporosis is a sizable comorbidity complication in Rheumatoid Arthritis (RA) sufferers. In the current study, the prevalence of osteopenia and osteoporosis in active RA sufferers and the association of disease-related factors of osteoporosis and reduced bone mineral density (BMD) have been examined.

Methods: In this cross-sectional study, 300 new-onset symptoms (less than one year) RA patients without a history of glucocorticoids or DMARDs were selected. Biochemical blood measurements and BMD status were performed with dual-energy X-ray absorptiometry. According to the T-scores of the patients, they were divided into three groups: osteoporosis<-2.5, -2.5 < osteopenia <-1, and - 1 < normal. Also, the MDHAQ questionnaire, DAS-28, and FRAX criteria were calculated for all patients. Multivariate logistic regression was used to determine the associated factors of osteoporosis and osteopenia.

Results: The Prevalence of osteoporosis and osteopenia was 27% (95%CI:22-32) and 45% (95%CI:39-51), respectively. The multivariate regression analysis showed that age could play a role as an associated factor for spine/hip Osteoporosis and Osteopenia. The female gender is also a predictor of Spine osteopenia Patients with Total hip Osteoporosis were more likely to have higher DAS-28 (OR 1.86, CI 1.16-3.14) and positive CRP (OR 11.42, CI 2.65-63.26).

Conclusion: recent-onset RA patients are at risk for osteoporosis and its complications, regardless of using glucocorticoids or DMARDs. Demographic factors (e.g. age and female gender), patients' MDHAQ scores, and disease-related factors(e.g., DAS-28, positive CRP were associated with reduced BMD levels. Therefore, it is recommended that clinicians investigate early BMD measurements to have a reasonable judgment for further interventions.

Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-023-01200-w.

References

Hauser B, Riches P, Wilson J, Horne A, Ralston S . Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford). 2014; 53(10):1759-66. DOI: 10.1093/rheumatology/keu162. View

Moller-Bisgaard S, Horslev-Petersen K, Ejbjerg B, Hetland M, Ornbjerg L, Glinatsi D . Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial. JAMA. 2019; 321(5):461-472. PMC: 6440221. DOI: 10.1001/jama.2018.21362. View

Garm Blavnsfeldt A, de Thurah A, Thomsen M, Tarp S, Langdahl B, Hauge E . The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials. Bone. 2018; 114:172-180. DOI: 10.1016/j.bone.2018.06.008. View

Makhdoom A, Rahopoto M, Awan S, Tahir S, Memon S, Siddiqui K . Bone mineral density level by dual energy X-ray absorptiometry in rheumatoid arthritis. J Pak Med Assoc. 2017; 67(1):15-19. View

Tillmann T, Krishnadas R, Cavanagh J, Petrides K . Possible rheumatoid arthritis subtypes in terms of rheumatoid factor, depression, diagnostic delay and emotional expression: an exploratory case-control study. Arthritis Res Ther. 2013; 15(2):R45. PMC: 3672797. DOI: 10.1186/ar4204. View

Aho K, Kaipiainen-Seppanen O, Heliovaara M, Klaukka T . Epidemiology of rheumatoid arthritis in Finland. Semin Arthritis Rheum. 1998; 27(5):325-34. DOI: 10.1016/s0049-0172(98)80053-x. View

Choi S, Kwon S, Jung J, Kim H, Kim S, Kim S . Prevalence and Fracture Risk of Osteoporosis in Patients with Rheumatoid Arthritis: A Multicenter Comparative Study of the FRAX and WHO Criteria. J Clin Med. 2018; 7(12). PMC: 6306752. DOI: 10.3390/jcm7120507. View

Pincus T, Yazici Y, Bergman M . Development of a multi-dimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical care. Clin Exp Rheumatol. 2005; 23(5 Suppl 39):S19-28. View

Ishii S, Cauley J, Greendale G, Crandall C, Danielson M, Ouchi Y . C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res. 2013; 28(7):1688-98. PMC: 3880424. DOI: 10.1002/jbmr.1915. View

10.

Hashimoto J . [Bone densitometry in patients with rheumatoid arthritis]. Nihon Rinsho. 2005; 63 Suppl 1:410-6. View

11.

Kanis J, Johnell O, Oden A, Johansson H, McCloskey E . FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008; 19(4):385-97. PMC: 2267485. DOI: 10.1007/s00198-007-0543-5. View

12.

Xu W, Perera S, Medich D, Fiorito G, Wagner J, Berger L . Height loss, vertebral fractures, and the misclassification of osteoporosis. Bone. 2010; 48(2):307-11. PMC: 3021585. DOI: 10.1016/j.bone.2010.09.027. View

13.

Tsao L . Relieving discomforts: the help-seeking experiences of Chinese perimenopausal women in Taiwan. J Adv Nurs. 2002; 39(6):580-8. DOI: 10.1046/j.1365-2648.2002.02327.x. View

14.

Haugeberg G, Uhlig T, Falch J, Halse J, Kvien T . Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum. 2000; 43(3):522-30. DOI: 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y. View

15.

Mikuls T, Saag K, Curtis J, Bridges Jr S, Alarcon G, Westfall A . Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data. J Natl Med Assoc. 2005; 97(8):1155-60. PMC: 1364462. View

16.

Felson D, Anderson J, Boers M, Bombardier C, Furst D, Goldsmith C . American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995; 38(6):727-35. DOI: 10.1002/art.1780380602. View

17.

Holmqvist M, Ljung L, Askling J . Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks. Ann Rheum Dis. 2017; 76(10):1642-1647. DOI: 10.1136/annrheumdis-2016-211066. View

18.

Adami G, Saag K . Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis. Curr Rheumatol Rep. 2019; 21(7):34. DOI: 10.1007/s11926-019-0836-7. View

19.

Lee J, Suh Y, Koh J, Jung S, Lee J, Kwok S . The risk of osteoporotic fractures according to the FRAX model in Korean patients with rheumatoid arthritis. J Korean Med Sci. 2014; 29(8):1082-9. PMC: 4129199. DOI: 10.3346/jkms.2014.29.8.1082. View

20.

Chen Y, Yu Z, Packham J, Mattey D . Influence of adult height on rheumatoid arthritis: association with disease activity, impairment of joint function and overall disability. PLoS One. 2013; 8(5):e64862. PMC: 3660323. DOI: 10.1371/journal.pone.0064862. View